Sepehr was designated in 2023 but the new sanctions go further by targeting the network underpinning Iran’s oil sales, ...
All political careers may end in failure, but the UK’s new ambassador to Washington, Peter Mandelson, isn’t done yet ...
European stock indices have outperformed the S&P 500 so far this year. The FT’s Aiden Reiter joins Katie Martin to discuss why investors are finally looking beyond US stocks and why Donald Trump’s ...
Last week, I wrote about US President Donald Trump’s administrative self-coup (or autogolpe) — his orders to the executive ...
To find out, the FT’s European economics commentator Martin Sandbu speaks to Dani Rodrik, professor of international political economy at Harvard. Rodrik is one of the world’s most acclaimed experts ...
Labour hemmed itself in by adopting the Conservatives’ “red lines” in its election manifesto last year: no return to the EU single market, customs union or freedom of movement. The urge not to scare ...
The weak outlook underlines the challenge facing chancellor Rachel Reeves after she pledged that growth was the government’s number one mission. It raised fresh questions about the fiscal outlook, ...
Potentially transformative, the idea has yet to show practical value, as the boundaries between the two fields shift ...
Generative AI may have transformative potential, but that comes at a cost, not least in terms of energy; a single data centre can consume the electricity equivalent to running 50, ...
Her specialism is occasionwear from the big French designers, and she has one of the most extensive collections of vintage Chanel out of any vintage shop in Paris (the brand’s Foundation recently came ...
The Bank of England has halved its 2025 growth forecast and cut interest rates by a quarter-point to 4.5 per cent, as it contends with a stagnant UK economy and an increasingly uncertain international ...
The world’s biggest drugmaker Eli Lilly has forecast that profits for the year will beat expectations, after two choppy quarters when disappointing sales of its blockbuster weight-loss drugs led to ...